EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ABCL: Abcellera Biologics Inc

06 Nov 25 08:01
LAST:

4.750

CHANGE:
 0.07		OPEN:
4.700		HIGH:
4.840		ASK:
0.000		VOLUME:
37.1K
CHG(%):
1.50		PREV:
4.680		LOW:
4.680		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Nov 254.7004.8404.6804.75037.1K
05 Nov 254.9505.1604.6704.6805.31M
04 Nov 255.1605.2404.8604.8704.53M
03 Nov 255.5505.6005.2105.3702.91M
31 Oct 255.3605.6755.3585.5503.2M
30 Oct 255.5405.6055.3405.3603.88M
29 Oct 255.6305.7905.4905.6203.93M
28 Oct 255.7605.7605.5555.6302.76M
27 Oct 255.7005.8005.5605.7703.92M
24 Oct 255.8405.9705.6405.6604.74M

COMPANY PROFILE

Name:Abcellera Biologics Inc
About:AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Sector:Healthcare
Industry:Biotechnology
Address:150 West 4th Ave, Vancouver, BC, Canada, V5Y 1G6
Website:https://www.abcellera.com
CUSIP:00288U106
CIK:0001703057
ISIN:CA00288U1066
FIGI:BBG00LLW2MF2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-9.76 
Forward P/E:-8.41 
PEG Ratio:1.27 
Price to Sales:50.45 
Price to Book:1.63 
Profit Margin:1.00 
Operating Margin:-2.90 
Return on Assets:-0.11 
Return on Equity:-0.16 
EPS Ratio:-0.56 
Revenue:32.88M 
Shares:298.83M 
Market Cap:1.419B 

TECHNICAL INDICATORS

MA5:5.046.1%
MA10:5.3212.1%
MA20:5.5116.0%
MA50:5.107.4%
MA100:4.662.0%
MA200:3.5932.2%
STO9:4.46 
STO14:3.64 
RSI14:33.33 
WPR14:-95.76 
MTM14:-1.13
ROC14:-0.19 
ATR:0.33 
Week High:5.6819.5%
Week Low:4.671.7%
Month High:6.5237.2%
Month Low:4.6732.2%
Year High:6.5237.2%
Year Low:1.89151.3%
Volatility:16.40